Who
Mani Sharma
Officer
Company insider
Files Form 4 as: SVP, Group Controller, AstraZeneca.
In numbers
- Trades disclosed
- 17
- Buys
- 1
- Sells
- 1
- Bought
- $6,497
- Sold
- $4.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Apr 2026
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $3202 at $159.80 | filing |
| 8 Sep 2026filed 11 Sep 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $1631 at $162.60 | filing |
| 8 Sep 2026filed 11 Sep 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $1631 at $162.60 | filing |
| 8 Aug 2026filed 11 Sep 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Bought | $3,24920.233 at $160.57 | filing |
| 8 Aug 2026filed 11 Sep 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Bought | $3,24820.23 at $160.57 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $3272 at $163.34 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $3272 at $163.34 | filing |
| 6 Jul 2026filed 8 Jul 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $3812 at $190.43 | filing |
| 6 Jul 2026filed 8 Jul 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $3812 at $190.43 | filing |
| 8 Jun 2026filed 16 Jun 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $1801 at $179.75 | filing |
| 8 Jun 2026filed 16 Jun 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $1801 at $179.75 | filing |
| 20 May 2026filed 22 May 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Sold | $2.2M11,893 at $185.78 | filing |
| 20 May 2026filed 22 May 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Sold | $2.2M11,893 at $185.78 | filing |
| 6 May 2026filed 8 May 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $1861 at $186.28 | filing |
| 6 May 2026filed 8 May 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $1861 at $186.28 | filing |
| 7 Apr 2026filed 8 May 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $1961 at $196.03 | filing |
| 7 Apr 2026filed 8 May 2026 | AZN AstraZenecaPharmaceuticals | SEC FORM 4 Code A | $1961 at $196.03 | filing |
News
Breast Cancer Canada and AstraZeneca Canada Advance Next-Generation Survivorship ResearchAZN · timminspress.com · 27 Oct 2026AstraZeneca offers compelling risk-reward into 2027 pipeline readouts, says JPMorganAZN · proactiveinvestors.com · 27 Oct 2026AstraZeneca Projects $80 Bln In Total Revenue By 2030, Sustained Growth BeyondAZN · rttnews.com · 27 Oct 2026
0 headlines in the last 90 days name Mani Sharma; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.
Sectors
Related people
Nobody else traded the same names lately.